Table 3 Sero-conversion rates as reported by Langley et al. [59], defined as the proportion of vaccinees with a pre-vaccination titer <1:10 and a post-vaccination titer ≥1:40, or a pre-vaccination titer ≥1:10 and at least a 4-fold increase in post-vaccination titer
TIV vaccination group | Seroconversion rate | |
|---|---|---|
With respect to B Yamagata | With respect to B Victoria | |
TIV-Vic (n = 870) | 41.3% (n = 359) | 71.5% (n = 622) |
TIV-Yam (n = 877) | 73.4% (n = 644) | 29.9% (n = 262) |